Sarris Maria, Konopka Michael, Lee C Soon
Royal Prince Alfred Hospital and Department of Pathology, University of Sydney, Sydney, NSW, Australia.
Pathology. 2003 Feb;35(1):37-41.
Some studies have shown that abnormalities of the nm23 gene or its expression may be important in tumour dissemination, suggesting that the gene may have metastasis suppressing activity. This study set out to determine if nm23 protein expression is altered with progression and dissemination in oesophageal adenocarcinoma.
Paraffin-embedded, archival tissues of surgical resection specimens of oesophageal adenocarcinoma (n=46), some of which were accompanied by tissue from areas with high-grade dysplasia (n=24) and from metastasis in regional lymph nodes (n=16) were studied. Histologically normal oesophageal glandular tissue (of cardiac-type) (n=32) obtained from areas of the resections located away from the primary tumour masses and archival tissues of Barrett's metaplasia obtained from endoscopic biopsies (n=77) were used as non-neoplastic controls. Sections were immunohistochemically stained by the labelled streptavidin-biotin method using NCL-nm23 antibody.
The total or overall amount of nm23 protein expression paralleled that of cytoplasmic expression and was increased in oesophageal adenocarcinomas (36/46 cases, 78%) when compared with normal oesophageal glandular epithelium (2/32, 6%), Barrett's metaplasia (8/77, 10%) and dysplasia (14/24, 58%). In metastatic carcinoma in regional lymph nodes, overall nm23 expression was similar in proportion (13/16, 81%) to that seen in primary carcinoma. In the analysis of the sequential development of oesophageal adenocarcinoma based on non-neoplastic, preneoplastic and neoplastic archival material, it was found that a high level of overall nm23 expression occurred firstly at the transition from Barrett's metaplasia (8/77, 10%) to dysplasia (14/24, 58%). Nuclear nm23 expression was low in dysplastic tissue (with none of the cases having a high level of nuclear nm23 expression) followed by increased levels as the lesion progressed to invasive adenocarcinoma (13/46, 28%) and metastatic carcinoma in regional lymph nodes (10/16, 63%). However, nm23 expression did not appear to correlate with sex, age, tumour size, extent of tumour infiltration into the oesophageal wall, presence of lymph node metastasis or overall patient survival.
An overall increase in nm23 expression or increase in nm23 expression in the cytoplasm of cells may be important in the early development of oesophageal adenocarcinoma but increased levels of nuclear nm23 occur in its progression to metastatic disease.
一些研究表明,nm23基因异常或其表达在肿瘤播散中可能起重要作用,提示该基因可能具有转移抑制活性。本研究旨在确定nm23蛋白表达是否随食管腺癌的进展和播散而改变。
研究了食管腺癌手术切除标本的石蜡包埋存档组织(n = 46),其中一些伴有高级别发育异常区域的组织(n = 24)和区域淋巴结转移组织(n = 16)。从远离原发性肿瘤块的切除区域获得的组织学正常的食管腺组织(贲门型)(n = 32)和从内镜活检获得的巴雷特化生存档组织(n = 77)用作非肿瘤对照。切片采用标记链霉亲和素-生物素法,用NCL-nm23抗体进行免疫组织化学染色。
nm23蛋白表达的总量或总体水平与细胞质表达平行,与正常食管腺上皮(2/32,6%)、巴雷特化生(8/77,10%)和发育异常(14/24,58%)相比,食管腺癌中nm23蛋白表达增加(36/46例,78%)。在区域淋巴结转移癌中,nm23的总体表达比例(13/16,81%)与原发性癌相似。在基于非肿瘤、肿瘤前和肿瘤存档材料对食管腺癌的序贯发展分析中,发现nm23总体表达高水平首先出现在从巴雷特化生(8/77,10%)向发育异常(14/24,58%)的转变过程中。发育异常组织中nm23核表达较低(所有病例均无高水平的nm23核表达),随后随着病变进展为浸润性腺癌(13/46,28%)和区域淋巴结转移癌(10/16,63%),nm23核表达水平升高。然而,nm23表达似乎与性别、年龄肿瘤大小、肿瘤浸润食管壁的程度、淋巴结转移的存在或患者总体生存率无关。
nm23表达总体增加或细胞胞质中nm23表达增加在食管腺癌的早期发展中可能起重要作用,但在其进展为转移性疾病过程中nm23核水平升高。